insulin aspart-fsan
insulin aspart-fsan is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Garzulys. Available dosage form: injection, solution.
Drug details
- Generic Name
- insulin aspart-fsan
- Brand Names
- Garzulys
- Application Number
- BLA761497
- Sponsor
- Meitheal Pharmaceuticals Inc.
- NDC Codes
- 2
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- INTRAVENOUS, SUBCUTANEOUS
- Active Ingredients
- INSULIN ASPART
Indications and Usage
1 INDICATIONS AND USAGE Garzulys™ is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. Garzulys is rapid acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus ( 1 ).